OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.680
-0.030 (-1.75%)
At close: Mar 12, 2026, 4:00 PM EDT
1.700
+0.020 (1.19%)
After-hours: Mar 12, 2026, 4:10 PM EDT
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $86.3 million as of March 12, 2026. Its market cap has increased by 115.51% in one year.
Market Cap
86.30M
Enterprise Value
80.73M
1-Year Change
115.51%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $86.30M, a decrease of -38.88%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 87.33M | 12.17% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 92.84M |
| aTyr Pharma | 91.76M |
| MAIA Biotechnology | 87.99M |
| PMV Pharmaceuticals | 86.39M |
| Spruce Biosciences | 86.15M |
| Pliant Therapeutics | 85.41M |
| Q32 Bio | 83.69M |
| PolyPid | 83.58M |